Baricitinib phosphate salt / 1187595-84-1

• Post Date:

  Aug 18,2016

• Expiry Date:

  Aug 18,2017

• Detailed Description:

  Cas No. :1187595-84-1 Quantity: 0.1Kilograms
  Specs:98%min
  Price:100 USD Kilograms
  Payment Method: T/T
  Baricitinib is an oral JAK1 and JAK2 inhibitor. Baricitinib is in Phase III development as a potential treatment for rheumatoid arthritis. It is in Phase II development as a potential treatment for psoriasis and diabetic nephropathy. The related compound in JAK inhibitor is Tofacitinib, currently approved for the treatment of rheumatoid arthritis in the United States.

• CAS Registry Number:

  1187595-84-1

• Synonyms:

  ;[1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl]acetonitrile phosphate;2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile phosphate;

• Company:

  Shanghai Biopharmaleader Co.,Ltd     [ China ]        

• Contact:

  Brenda Xu

• Tel:

  021-50180596

• Fax:

  021-57758967

• Email:

  brenda@biopharmaleader.com